Pilot trial to prevent type I diabetes: Progression to overt IDDM despite oral nicotinamide
- 31 October 1989
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 2 (5) , 733-737
- https://doi.org/10.1016/s0896-8411(89)80011-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicityDiabetes, 1988
- NICOTINAMIDE MAY EXTEND REMISSION PHASE ININSULIN-DEPENDENT DIABETESThe Lancet, 1987
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regenerationDiabetes, 1984
- Response of generalized granuloma annulare to high-dose niacinamideArchives of Dermatology, 1983
- Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesisDiabetes, 1983
- Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) miceDiabetes, 1982
- Reactions to niacinamideJournal of the American Academy of Dermatology, 1981
- Hepatic Toxicity from Large Doses of Vitamin B3(Nicotinamide)New England Journal of Medicine, 1973
- An Evaluation of Niacinamide in the Treatment of Childhood SchizophreniaAmerican Journal of Psychiatry, 1970